December 17, 2019 / 6:23 AM / a month ago

Roche has 60.4% of Spark, plans to wrap up takeover on Tuesday

ZURICH, Dec 17 (Reuters) - Swiss drugmaker Roche Holding plans to complete on Tuesday its $4.3 billion takeover of Spark Therapeutics, it said, after winning U.S. regulatory approval for the long-delayed deal.

Roche said approximately 60.4% of the total number of shares of Spark's common stock outstanding had been tendered in its offer for the gene therapy specialist. (Reporting by Michael Shields; editing by Thomas Seythal)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below